US Patent 7910626 Use of S1P receptor agonists in heart diseases

Patent 7910626 was granted and assigned to Novartis on March, 2011 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Patent Inventor Names

Volker Brinkmann0

Gilles Feutren0

Robert Paul Hof0

Date of Patent

March 22, 2011

Patent Application Number

122444220

Date Filed

October 2, 2008

Patent Primary Examiner

Patent abstract

The invention relates to the use of a sphingosine-1-phosphate receptor agonist in the treatment of heart diseases.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7910626 Use of S1P receptor agonists in heart diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.